| Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor) N Schmitz, P Dreger, M Suttorp, EB Rohwedder, T Haferlach, H Löffler, ... Blood 85 (6), 1666-1672, 1995 | 628 | 1995 |
| Treatment of patients with advanced cancer with the natural killer cell line NK-92 T Tonn, D Schwabe, HG Klingemann, S Becker, R Esser, U Koehl, ... Cytotherapy 15 (12), 1563-1570, 2013 | 517 | 2013 |
| G‐CSF‐mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft P Dreger, T Haferlach, V Eckstein, S Jacobs, M Suttorp, H Löuffler, ... British journal of haematology 87 (3), 609-613, 1994 | 418 | 1994 |
| Pediatric chronic myeloid leukemia is a unique disease that requires a different approach N Hijiya, KR Schultz, M Metzler, F Millot, M Suttorp Blood, The Journal of the American Society of Hematology 127 (4), 392-399, 2016 | 236 | 2016 |
| Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids N Bruck, M Suttorp, M Kabus, G Heubner, M Gahr, F Pessler JCR: Journal of Clinical Rheumatology 17 (1), 23-27, 2011 | 185 | 2011 |
| Malignancy‐associated haemophagocytic lymphohistiocytosis in children and adolescents K Lehmberg, B Sprekels, KE Nichols, W Woessmann, I Müller, M Suttorp, ... British journal of haematology 170 (4), 539-549, 2015 | 179 | 2015 |
| Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation P Dreger, M Suttorp, T Haferlach, H Loffler, N Schmitz, W Schroyens | 179 | 1993 |
| Detection of human disease conditions by single-cell morpho-rheological phenotyping of blood N Toepfner, C Herold, O Otto, P Rosendahl, A Jacobi, M Kräter, ... elife 7, e29213, 2018 | 161 | 2018 |
| Treatment of pediatric chronic myeloid leukemia in the year 2010: use of tyrosine kinase inhibitors and stem-cell transplantation M Suttorp, F Millot Hematology 2010, the American Society of Hematology Education Program Book …, 2010 | 143 | 2010 |
| Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. F Locatelli, C Niemeyer, E Angelucci, C Bender-Götze, S Burdach, ... Journal of clinical oncology 15 (2), 566-573, 1997 | 134 | 1997 |
| Managing children with chronic myeloid leukaemia (CML) Recommendations for the management of CML in children and young people up to the age of 18 years J de la Fuente, A Baruchel, A Biondi, E de Bont, MF Dresse, M Suttorp, ... British journal of haematology 167 (1), 33-47, 2014 | 131 | 2014 |
| Imatinib mesylate is effective in children with chronic myelogenous leukemia in late chronic and advanced phase and in relapse after stem cell transplantation F Millot, J Guilhot, B Nelken, T Leblanc, ES De Bont, AN Bekassy, ... Leukemia 20 (2), 187-192, 2006 | 127 | 2006 |
| Specificity of purified monoacylglycerol lipase, palmitoyl-CoA hydrolase, palmitoyl-carnitine hydrolase, and nonspecific carboxylesterase from rat liver microsomes R Mentlein, M Suttorp, E Heymann Archives of Biochemistry and Biophysics 228 (1), 230-246, 1984 | 127 | 1984 |
| How I treat chronic myeloid leukemia in children and adolescents N Hijiya, M Suttorp Blood, The Journal of the American Society of Hematology 133 (22), 2374-2384, 2019 | 124 | 2019 |
| Front-line imatinib treatment in children and adolescents with chronic myeloid leukemia: results from a phase III trial M Suttorp, P Schulze, I Glauche, G Göhring, N von Neuhoff, M Metzler, ... Leukemia 32 (7), 1657-1669, 2018 | 113 | 2018 |
| The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease HB Huttner, P Janich, M Köhrmann, J Jászai, F Siebzehnrubl, I Blümcke, ... Stem cells 26 (3), 698-705, 2008 | 106 | 2008 |
| Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin lymphoma: an analysis of the European Group for Blood and … A Claviez, C Canals, D Dierickx, J Stein, I Badell, A Pession, S Mackinnon, ... Blood, The Journal of the American Society of Hematology 114 (10), 2060-2067, 2009 | 99 | 2009 |
| Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias N Schmitz, W Gassmann, M Rister, W Johannson, M Suttorp, F Brix, ... | 95 | 1988 |
| Intriguing response to azacitidine in a patient with juvenile myelomonocytic leukemia and monosomy 7 I Furlan, C Batz, C Flotho, B Mohr, M Lübbert, M Suttorp, CM Niemeyer Blood, The Journal of the American Society of Hematology 113 (12), 2867-2868, 2009 | 94 | 2009 |
| Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group A Cseh, CM Niemeyer, A Yoshimi, M Dworzak, H Hasle, ... Blood, The Journal of the American Society of Hematology 125 (14), 2311-2313, 2015 | 93 | 2015 |
